1:32 PM
 | 
Nov 10, 2017
 |  BC Week In Review  |  Financial News  |  Completed Offerings

Nouscom raises €42M series B

Cancer vaccine play Nouscom AG (Basel, Switzerland) raised €42 million ($48.8 million) in a series B round led by Abingworth. Fellow new investor 5AM Ventures also participated,...

Read the full 112 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >